Tom Wilton
Corporate Officer/Principal chez CARISMA THERAPEUTICS, INC.
Postes actifs de Tom Wilton
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2019 | - |
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Historique de carrière de Tom Wilton
Formation de Tom Wilton
| University of London | Undergraduate Degree |
| University of Leeds | Graduate Degree |
| Brunel University | Graduate Degree |
Statistiques
Internationale
| Royaume-Uni | 4 |
| Etats-Unis | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Bourse
- Insiders
- Tom Wilton
- Expérience